Emerging cancer vaccines: the promise of genetic vectors.
about
Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphomaImmunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models.Construction and characterization of E1- and E3-deleted adenovirus vectors expressing two antigens from two separate expression cassettes.Genetic cancer vaccines: current status and perspectives.Kinesin spindle protein SiRNA slows tumor progression.
P2860
Emerging cancer vaccines: the promise of genetic vectors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging cancer vaccines: the promise of genetic vectors.
@en
Emerging cancer vaccines: the promise of genetic vectors.
@nl
type
label
Emerging cancer vaccines: the promise of genetic vectors.
@en
Emerging cancer vaccines: the promise of genetic vectors.
@nl
prefLabel
Emerging cancer vaccines: the promise of genetic vectors.
@en
Emerging cancer vaccines: the promise of genetic vectors.
@nl
P2860
P356
P1433
P1476
Emerging cancer vaccines: the promise of genetic vectors
@en
P2093
Luigi Aurisicchio
P2860
P304
P356
10.3390/CANCERS3033687
P577
2011-09-22T00:00:00Z